Skip to main content
Figure 3 | BMC Veterinary Research

Figure 3

From: Is switching from brand name to generic formulations of phenobarbital associated with loss of antiepileptic efficacy?: a pharmacokinetic study with two oral formulations (Luminal® vet, Phenoleptil®) in dogs

Figure 3

Correlation between individual phenobarbital doses and maximal plasma concentrations. As a result of the different body weights of the 8 dogs, doses of phenobarbital ranged between 5.8 and 11.1 mg/kg, resulting in different peak plasma levels (Cmax). As shown in the graph, a linear correlation between Cmax and dose was obtained for both phenobarbital formulations without difference between formulations.

Back to article page